ストックスクリーナーアプリを入手
11.62
1.31%
0.1382
前日終値:
$11.48
開ける：
$11.57
24時間の取引高:
508.71K
Relative Volume:
0.40
時価総額：
$1.13B
収益：
-
当期純損益:
$-137.25M
株価収益率:
-6.1472
EPS:
-1.89
ネットキャッシュフロー:
$-121.97M
1週間 パフォーマンス:
-5.06%
1か月 パフォーマンス:
-7.70%
6か月 パフォーマンス:
+98.13%
1年 パフォーマンス:
+27.52%
1日の値動き範囲:
$11.02
$11.70
1週間の範囲:
$11.02
$12.71
52週間の値動き範囲:
$3.8951
$14.93
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
名前
Oric Pharmaceuticals Inc
セクター
電話
(650) 388-5600
住所
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
ORIC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
11.60 | 1.12B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
431.25 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.72 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.20 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.42 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.38 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-20 | 開始されました | Evercore ISI | Outperform |
| 2025-11-18 | 開始されました | Wolfe Research | Peer Perform |
| 2025-09-04 | 再開されました | Guggenheim | Buy |
| 2025-07-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-10-31 | 開始されました | Wells Fargo | Overweight |
| 2024-09-06 | 開始されました | Stifel | Buy |
| 2024-02-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-09-22 | 開始されました | Wedbush | Outperform |
| 2023-03-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-07-18 | 再開されました | Oppenheimer | Perform |
| 2022-04-04 | アップグレード | Citigroup | Neutral → Buy |
| 2022-03-25 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-22 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-03-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2021-01-25 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-08-13 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-03 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-19 | 開始されました | Citigroup | Neutral |
| 2020-05-19 | 開始されました | Guggenheim | Buy |
| 2020-05-19 | 開始されました | JP Morgan | Overweight |
| 2020-05-19 | 開始されました | Jefferies | Buy |
すべてを表示
Oric Pharmaceuticals Inc (ORIC) 最新ニュース
Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated at Evercore ISI - MarketBeat
Evercore ISI Group Initiates Coverage of ORIC Pharmaceuticals (ORIC) with Outperform Recommendation - MSN
Oric Pharmaceuticals (ORIC) Upgraded to Buy: Here's What You Should Know - MSN
This Astera Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
ORIC Pharmaceuticals (ORIC) Initiates Coverage with Outperform Rating | ORIC Stock News - GuruFocus
Is ORIC Pharmaceuticals Inc. (4TZ) stock positioned for secular growthChart Signals & High Win Rate Trade Tips - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock attracts HNW investorsEarnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Is ORIC Pharmaceuticals Inc. (4TZ) stock attractive for growth funds2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Can ORIC Pharmaceuticals Inc. stock resist sector downturnsJuly 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com
Is ORIC Pharmaceuticals Inc. stock undervalued vs historical averagesEarnings Miss & Consistent Growth Stock Picks - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock benefits from AI revolutionQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Will ORIC Pharmaceuticals Inc. stock maintain momentum in 2025July 2025 Trends & Stepwise Trade Signal Guides - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
ORIC: ORIC-944 demonstrates high ctDNA clearance and safety, supporting pivotal trials and market expansion - TradingView
Wolfe Research Initiates Coverage on Oric Pharmaceuticals (NASDAQ:ORIC) - MarketBeat
Why institutional investors increase stakes in ORIC Pharmaceuticals Inc. (4TZ) stock2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
The Technical Signals Behind (ORIC) That Institutions Follow - news.stocktradersdaily.com
Why ORIC Pharmaceuticals Inc. stock could see breakout soon2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Is this a good reentry point in ORIC Pharmaceuticals Inc.2025 Historical Comparison & Stock Market Timing Techniques - newser.com
Analyst Initiation: Wolfe Research Rates ORIC Pharmaceuticals as 'Peer Perform' | ORIC Stock News - GuruFocus
JP Morgan Raises ORIC Pharmaceuticals (ORIC) Price Target to $20 - GuruFocus
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
Can you recover from losses in ORIC Pharmaceuticals Inc.Weekly Volume Report & Entry and Exit Point Strategies - newser.com
Wolfe Research initiates coverage on ORIC Pharmaceuticals stock with Peerperform rating - Investing.com Canada
Citigroup Raises ORIC Pharmaceuticals Price Target to $16 | ORIC Stock News - GuruFocus
Relative strength of ORIC Pharmaceuticals Inc. in sector analysisJuly 2025 Market Mood & Target Return Focused Picks - newser.com
ORIC Pharma Surges Ahead With ORIC-944 And Enozertinib Data Momentum - RTTNews
Oric Pharmaceuticals' (ORIC) "Outperform" Rating Reaffirmed at Wedbush - MarketBeat
Why analysts recommend ORIC Pharmaceuticals Inc. (4TZ) stockWeekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Oric Pharmaceuticals’ 2025 Restructuring: Potential Risks and Financial Implications - TipRanks
Wells Fargo & Company Lowers Oric Pharmaceuticals (NASDAQ:ORIC) Price Target to $19.00 - MarketBeat
Oric Pharmaceuticals Inc (ORIC) 財務データ
収益
当期純利益
現金流量
EPS
Oric Pharmaceuticals Inc (ORIC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer |
Oct 06 '25 |
Sale |
14.52 |
11,000 |
159,719 |
48,317 |
| Chacko Jacob | PRESIDENT AND CEO |
Oct 06 '25 |
Sale |
12.32 |
37,461 |
461,520 |
531,419 |
1.75%
0.74%
大文字化:
|
ボリューム (24 時間):